eMeistring

eMeistring is a platform for supervised online treatment of mental illnesses.

eMeistring enhances services offered to people with mental illnesses. Supervised online treatment can reach new groups of patients who would otherwise have a high threshold for seeking help, and thus supports the goal of increasing access to effective health services. It may also increase the processing power of each therapist. Altogether, this increases the availability of knowledge-based services for people with mental illnesses.

Supervised online treatment contains the same elements as traditional cognitive behavioural therapy (CBT) with a treater in a policlinic, and is based on research. The treatment is modular and lasts up to 14 weeks. Every week you will follow directions from one treater who guides you through the treatment via the internet.

To receive the treatment you must be over 18 years old, and your family doctor must refer you to one of the polyclinics in Helse Bergen in the normal manner.

The project has received funding from Helse Vest, and 10 mNOK from the Health Department over three years to develop and test the programme.

We are open to any academic collaboration and requests from hospitals that would like to consider using this treatment method.

Follow eMeistring on Facebok.

Other projects

Doctors performing a procedure on a patient.
Cryoimmunotherapy

Every year, 5000 Norwegian men is diagnosed with prostate cancer and approximately 20% of them die. Cryoimmunotherapy is a new treatment for prostate cancer that mobilizes the patient’s own immune system to attack the cancer cells.

Read more
The Holberg EEG team
Holberg EEG

SCORE (Standardised Computer-based Organised Reporting of EEG) is the new European standard for reporting EEG. It is a software with an associated database, which is used to categorise and describe EEG examinations.

Read more
Nurse taking blood sample from the heel of an infant.
New treatment for rare disease will help children

One out of 10 000 children all over the world is born with the rare metabolic disorder phenylketonuria (PKU). Researchers from Bergen develops a treatment against the disorder, and their research are promising.

Read more